These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17704152)

  • 1. How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation.
    Huang X; Zhan CG
    Biophys J; 2007 Nov; 93(10):3627-39. PubMed ID: 17704152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter.
    Cheng MH; Bahar I
    Structure; 2015 Nov; 23(11):2171-81. PubMed ID: 26481814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.
    Indarte M; Madura JD; Surratt CK
    Proteins; 2008 Feb; 70(3):1033-46. PubMed ID: 17847094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights from molecular dynamics: the binding site of cocaine in the dopamine transporter and permeation pathways of substrates in the leucine and dopamine transporters.
    Merchant BA; Madura JD
    J Mol Graph Model; 2012 Sep; 38():1-12. PubMed ID: 23079638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microscopic binding of M5 muscarinic acetylcholine receptor with antagonists by homology modeling, molecular docking, and molecular dynamics simulation.
    Huang X; Zheng G; Zhan CG
    J Phys Chem B; 2012 Jan; 116(1):532-41. PubMed ID: 22185605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations.
    Huang X; Gu HH; Zhan CG
    J Phys Chem B; 2009 Nov; 113(45):15057-66. PubMed ID: 19831380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneities in Axonal Structure and Transporter Distribution Lower Dopamine Reuptake Efficiency.
    Kaya C; Cheng MH; Block ER; Bartol TM; Sejnowski TJ; Sorkin A; Faeder JR; Bahar I
    eNeuro; 2018; 5(1):. PubMed ID: 29430519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer.
    Gedeon PC; Indarte M; Surratt CK; Madura JD
    Proteins; 2010 Mar; 78(4):797-811. PubMed ID: 19899168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimerization of dopamine transporter triggered by AIM-100 binding: Molecular mechanism and effect of mutations.
    Cheng MH; Ponzoni L; Sorkina T; Lee JY; Zhang S; Sorkin A; Bahar I
    Neuropharmacology; 2019 Dec; 161():107676. PubMed ID: 31228486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.
    Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR
    Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the human dopamine transporter in complex with cocaine.
    Nielsen JC; Salomon K; Kalenderoglou IE; Bargmeyer S; Pape T; Shahsavar A; Loland CJ
    Nature; 2024 Aug; 632(8025):678-685. PubMed ID: 39112703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Assessment of the Energetics of Dopamine Translocation by Human Dopamine Transporter.
    Cheng MH; Kaya C; Bahar I
    J Phys Chem B; 2018 May; 122(21):5336-5346. PubMed ID: 29232131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordination of Na(+) by monoamine ligands in dopamine, norepinephrine, and serotonin transporters.
    Xhaard H; Backström V; Denessiouk K; Johnson MS
    J Chem Inf Model; 2008 Jul; 48(7):1423-37. PubMed ID: 18543980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dopamine transporter: the first implementation of a combined in silico/in vitro approach revealing the substrate and inhibitor specificities.
    Djikic T; Martí Y; Spyrakis F; Lau T; Benedetti P; Davey G; Schloss P; Yelekci K
    J Biomol Struct Dyn; 2019 Feb; 37(2):291-306. PubMed ID: 29334320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intracellular interaction network regulates conformational transitions in the dopamine transporter.
    Kniazeff J; Shi L; Loland CJ; Javitch JA; Weinstein H; Gether U
    J Biol Chem; 2008 Jun; 283(25):17691-701. PubMed ID: 18426798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition.
    Zeppelin T; Ladefoged LK; Sinning S; Periole X; Schiøtt B
    PLoS Comput Biol; 2018 Jan; 14(1):e1005907. PubMed ID: 29329285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific amino acid recognition by aspartyl-tRNA synthetase studied by free energy simulations.
    Archontis G; Simonson T; Moras D; Karplus M
    J Mol Biol; 1998 Feb; 275(5):823-46. PubMed ID: 9480772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.
    Yuan Y; Huang X; Midde NM; Quizon PM; Sun WL; Zhu J; Zhan CG
    ACS Chem Neurosci; 2015 Apr; 6(4):658-665. PubMed ID: 25695767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Isomeric Preference of an Atypical Dopamine Transporter Inhibitor Contributes to Its Selection of the Transporter Conformation.
    Abramyan AM; Stolzenberg S; Li Z; Loland CJ; Noé F; Shi L
    ACS Chem Neurosci; 2017 Aug; 8(8):1735-1746. PubMed ID: 28441487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling using simulated annealing of restrained molecular dynamics and conformational search calculations with CONGEN: application in predicting the three-dimensional structure of murine homeodomain Msx-1.
    Li H; Tejero R; Monleon D; Bassolino-Klimas D; Abate-Shen C; Bruccoleri RE; Montelione GT
    Protein Sci; 1997 May; 6(5):956-70. PubMed ID: 9144767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.